The 21st Awaji International Forum on Infection and Immunity
The 21st Awaji International Forum on Infection and Immunity

The 21st Awaji International Forum on Infection and Immunity concluded successfully with many participants.
Your contribution has been very much appreciated.

Next AIFII will be held from Sep 17-19, 2024.
We are looking forward to seeing you again.

  Venue: ROHM Theatre Kyoto
  Chair: Keizo Tomonaga (Institute for Life and Medical Sciences, Kyoto University)

Science for delivering vaccine in 100 days


Dates
September 3-6, 2023
Venue
Karuizawa Prince Hotel West
Chair
Ken J. Ishii (U Tokyo)
▼Download Meeting Badge and Receipt
▼Register for the Forum (Aug 30 - Sep 6)
▼Program & Abstract Viewing System (Confit)
主催
共催・協賛

News & Information

2023.8.21

General Information for Participants has been released.

2023.8.18

Information for Chairs and Presenters has been released.

2023.8.10

Program at a Glance has opened.

2023.7.10

Abstract Submission has been closed.

2023.6.28

The abstract submission period was extended.

2023.6.14

Application for Travel Bursary was closed.

2023.5.17

Registration, Call for papers, Application for Travel Bursary have been started.

2023.4.28

Our Website has been opened.

Organized by

  • Research Institute for Microbial Diseases *
  • The Institute of Medical Science, The University of Tokyo *
  • Institute for Life and Medical Sciences, Kyoto University *
  • Hokkaido University International Institute for Zoonosis Control *
  • Institute of Tropical Medicine, Nagasaki University *

  (*Joint Usage/Research Centers of National Universities)

  (Japanese Union for the Promotion of Infectious Disease Knowledge through Research and Education (JUPITRE))

Co-organized by

  • Moonshot Research and Development Program "Understanding and Control of Virus-Human Interaction Networks"
  • Center for Infectious Disease Education and Research, Osaka University

Sponsored by

  • Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response : SCARDA "Program on R&D of New Generation Vaccine including New Modality Application" and "Japan Initiative for World-leading Vaccine Research and Development Centers"